In addition, BRCA1 mRNA expression was negatively correlated with cisplatin sensitivity in peritoneal effusions of gastric cancer patients, while ERCC1 was correlated with cisplatin sensitivity only in specimens of untreated gastric patients. This evidence concerns the gene ERCC1 and gastric cancer.